efficacy of aterosclerosis of tofacitinib in rheumatoid arthritis

Phase 4

• Conditions: atherosclerosis efficacy of tofacitinib in RA

• Registration Number: JPRN-UMIN000024143
• Lead Sponsor: hiroshima clinic

Brief Summary

under submitting to journal

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2016-08-31
• Study Start: 2016-09-23
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Not provided

Exclusion Criteria

NP

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
AS values in 54 weeks